Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.
New protein engineering method could accelerate the discovery of COVID-19 therapeutics eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Read Time:
Researchers from Ben-Gurion University (BGU), together with American and German colleagues, have developed new molecular tweezers to combat antibiotic-resistant bacteria. Their recently announced findings were published in Cell Chemical Biology.
For years, medical professionals have struggled with bacterial infections becoming increasingly resistant to antibiotics. These molecular tweezers may be the key to battling one of greatest public health issues of the 21st century. Our discovery prevents infection without building up antibiotic resistance, and it might even be preferable to develop treatments based on molecular tweezers rather than antibiotics, said BGU Department of Chemistry Prof. Raz Jelinek.
The research team, led by Prof. Jelinek and his Ph.D. student Ravit Malishev, tested their molecular tweezers on the Staphylococcus aureus (Staph) bacteria. In the U.S. staph infections have an estimated mortality rate of over 25%, and 40% for drug-resistant strai
New molecular tweezers can help combat antibiotic-resistant bacteria
Researchers from Ben-Gurion University (BGU), together with American and German colleagues, have developed new molecular tweezers to combat antibiotic-resistant bacteria. Their recently announced findings were published in
Cell Chemical Biology.
For years, medical professionals have struggled with bacterial infections becoming increasingly resistant to antibiotics. These molecular tweezers may be the key to battling one of greatest public health issues of the 21st century.
Our discovery prevents infection without building up antibiotic resistance, and it might even be preferable to develop treatments based on molecular tweezers rather than antibiotics.
Raz Jelinek, Professor, Department of Chemistry, Ben-Gurion University (BGU)
Credit: Dani Machlis/BGU
BEER-SHEVA, Israel May 10, 2021 - Researchers from Ben-Gurion University (BGU), together with American and German colleagues, have developed new molecular tweezers to combat antibiotic-resistant bacteria. Their recently announced findings were published in
Cell Chemical Biology.
For years, medical professionals have struggled with bacterial infections becoming increasingly resistant to antibiotics. These molecular tweezers may be the key to battling one of greatest public health issues of the 21st century. Our discovery prevents infection without building up antibiotic resistance, and it might even be preferable to develop treatments based on molecular tweezers rather than antibiotics, said BGU Department of Chemistry Prof. Raz Jelinek.